Wellness Holding ha diffuso questo post
Oura has hit a major milestone today; we’ve announced a strategic partnership with Dexcom, a global leader in glucose biosensing, and a $75 million investment from them, kicking off our Series D funding round that will value Oura at $5 billion. Our work together will accelerate our metabolic health offering and give us even deeper and more personalized insights to share with our members about their habits and behavior and how it impacts health. In mid-FY25, we’ll begin to co-market and cross-sell each other products, and more importantly, we’ll also integrate the two products (Oura Ring and Dexcom Stelo) so that data can flow between them to help people decide what and when to eat by surfacing correlations between activities like sleep and exercise and members’ glucose levels. Our metabolic health plans are ambitious, and we’re moving full steam ahead. We recently announced our acquisition of Veri, which has opened up our ability to integrate with Dexcom on a combined product experience. Together, we’ll create an integrated product offering that is holistic, intelligent, and rooted in building a healthy relationship with food. Our goals are big and ambitious, but we know they’re possible, especially when we join forces with leading-edge companies like Dexcom. We know that Oura has the potential to change lives at scale, and we’re passionate about our vision to make it a reality. #WithOura